Migalastat Hydrochloride

Drug Index

Migalastat, sold under the brand name Galafold, is a medication for the treatment of Fabry disease, a rare genetic disorder. It was developed by Amicus Therapeutics. The US Food and Drug Administration (FDA) granted it orphan drug status in 2004,[1] and the European Commission followed in 2006.[2] The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) granted the drug a marketing approval under the name Galafold in May 2016.&#...

NDC Database

Galafold 123 mg Oral Capsule by Amicus Therapeutics U.S., Inc. ## Markings: A1001 ## Shape: Capsule ## Package Codes: 71904-100-01 ## Active Ingredients: Migalastat Hydrochloride